Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Mpilla

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Seminars in Cancer Biology|February 16, 2019
Ras and exosome signalingRachel E Sexton, Gabriel Mpilla, Steve Kim, et al.
International Journal of Molecular Sciences|January 8, 2020
Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy ResistanceHusain Yar Khan, James Ge, Misako Nagasaka, et al.
Cancers|December 5, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine TumorsGabriel Mpilla, Amro Aboukameel, Irfana Muqbil, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Seminars in Cancer Biology|February 16, 2019
Ras and exosome signalingRachel E Sexton, Gabriel Mpilla, Steve Kim, et al.
International Journal of Molecular Sciences|January 8, 2020
Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy ResistanceHusain Yar Khan, James Ge, Misako Nagasaka, et al.
Cancers|December 5, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine TumorsGabriel Mpilla, Amro Aboukameel, Irfana Muqbil, et al.
Pageof 1